Genomics of Drug Sensitivity in Cancer |
GW-2580
|
Synonyms |
GX2580, CFMS receptor tyrosine kinase inhibitor
|
Targets |
CSF1R
|
Target pathway |
RTK signaling
|
PubCHEM ID |
11617559
|
Jsmol |
|
Download molecule |
11617559
|
PUBCHEM IUPAC INCHI |
InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)
|
Smiles |
O(C2(=C(OC)C=C(CC1(=C(N=C(N)N=C1)N))C=C2))CC3(=CC=C(OC)C=C3)
|
Cluster number |
69
|
calculated LogS |
-4,648
|
Molecular weight |
366,42
|
calculated LogP |
2,4867
|
H-Acceptors |
7
|
H-Donors |
2
|
Ro5 violations |
0
|
Druglikeness |
-1,8568
|
DrugScore |
0,397177104871468
|
Mutagenic |
none
|
Tumorigenic |
none
|
Reproductive Effective |
none
|
Irritant |
none
|
Fish Toxicity |
Low FHMT
|
Fish Toxicity2 |
1,8903
|
Rat Acute Toxicity |
1,8133
|
Acute Oral Toxicity |
III
|
Caco-2 Permeability |
Caco2+
|
Caco-2 Permeability2 |
1,5873
|
P-glycoprotein Substrate |
Non-substrate
|
P-glycoprotein Inhibitor |
Non-inhibitor
|
P-glycoprotein Inhibitor2 |
Non-inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition2 |
Non-inhibitor
|
Tetrahymena Pyriformis Toxicity |
High TPT
|
Tetrahymena Pyriformis Toxicity2 |
0,3515
|
AMES Toxicity |
AMES toxic
|
CYP450 2C9 Substrate |
Non-substrate
|
CYP450 3A4 Substrate |
Non-substrate
|
CYP450 3A4 Inhibitor |
Non-inhibitor
|
CYP450 2C19 Inhibitor |
Non-inhibitor
|
CYP450 2C9 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Inhibitor |
Non-inhibitor
|
CYP450 1A2 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Substrate |
Non-substrate
|
Biodegradation |
Not ready biodegradable
|
Carcinogenicity (Three-class) |
Non-carcinogens
|
Carcinogens |
Non-required
|
Blood-Brain Barrier |
BBB+
|
CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
Honey Bee Toxicity |
Low HBT
|
Renal Organic Cation Transporter |
Non-inhibitor
|
Subcellular localization |
Nucleus
|
Human Intestinal Absorption |
HIA+
|
Aqueous solubility |
-2,6435
|